EN DE
STOCK COMPARISON

Guangzhou Innogen Pharm Grp vs Vertex Pharmaceuticals: Fair Value & Quality

Both stocks run through our valuation models. Here is how Guangzhou Innogen Pharm Grp (2591) and Vertex Pharmaceuticals (VRTX) compare, as of Aug 17, 2026.

As of Aug 17, 2026, Fair Value Calculator sees Vertex Pharmaceuticals as the less overvalued of the two: Guangzhou Innogen Pharm Grp trades at HK$6.61 versus a fair value of HK$2.09 (-68%), while Vertex Pharmaceuticals trades at $506 versus $279 (-45%).
Guangzhou Innogen Pharm Grp
2591.HK · HKD · Healthcare
-68%
upside to fair value
overvalued
PriceHK$6.61
Fair ValueHK$2.09
Quality44/100
Vertex Pharmaceuticals
VRTX · USD · Health Care
-45%
upside to fair value
overvalued
Price$506
Fair Value$279
Quality79/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Guangzhou Innogen Pharm GrpVertex Pharmaceuticals
Valuation
—P/E (TTM)28.8×
3.45×P/S (TTM)10.06×
0.43×P/B6.59×
—EV/EBITDA23.8×
—PEG1.72×
—Dividend yield0.1%
Profitability
—Net margin36%
—Operating margin38%
-37%Return on equity24%
-17%Return on assets12%
Growth
0%Revenue growth (YoY)8%
—Avg. growth/yr (3Y)10.6%
—Avg. growth/yr (5Y)14.2%
Balance & size
—Debt / equity0.03×
$453MMarket cap$123B
weakGrowth qualityhealthy

Vertex Pharmaceuticals leads: 2 to 3 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Guangzhou Innogen Pharm Grpof which business quality 44 · market factors 0 Vertex Pharmaceuticalsof which business quality 77 · market factors 70
ProfitabilityMargins and returns on capital today
2
72
Quality GrowthAre margins and returns improving?
58
65
CashflowEarnings quality: real cash, not paper profit
9
79
Fin. StrengthBalance sheet, leverage, solvency risk
93
92
InvestmentDisciplined investing over empire-building
5
58
Low VolatilityCalm price path (market factor)
0
86
MomentumPrice trend over the last 3–12 months (market factor)
0
58
52W MomentumDistance to the 52-week high (market factor)
0
74
Net IssuanceBuybacks instead of dilution
100
82

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Guangzhou Innogen Pharm Grp

Asset-BasedHK$1.68

1 of 1 models see the stock below the current price.

Vertex Pharmaceuticals

DCF Models$453
Earnings-Based$516
Dividend Discount$7.07
Multiples$278
Asset-Based$49.27
Growth DCF$348
Economic Profit$254
Growth Earnings$692

19 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Guangzhou Innogen Pharm Grp
Bear HK$1.38Fair Value HK$2.09Bull HK$2.61
HK$6.61 = current price (white tick)
Vertex Pharmaceuticals
Bear $210Fair Value $279Bull $900
$506 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Guangzhou Innogen Pharm Grp · Healthcare

Quality score44 · below median
Fair value upside-68% · below median

Vertex Pharmaceuticals · Health Care

Quality score79 · Top 25%
Fair value upside-45% · below median

Bottom line

As of Aug 17, 2026, Fair Value Calculator sees Vertex Pharmaceuticals as the less overvalued of the two: Guangzhou Innogen Pharm Grp trades at HK$6.61 versus a fair value of HK$2.09 (-68%), while Vertex Pharmaceuticals trades at $506 versus $279 (-45%).

Vertex Pharmaceuticals has the higher quality score (79/100).

See the full analysis →
Guangzhou Innogen Pharm Grp · Vertex Pharmaceuticals

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Guangzhou Innogen Pharm Grp

Alphabet Inc Class C vs Verizon CommunicationsAlphabet Inc Class C vs At&tAlphabet Inc Class C vs NetEaseAmazon.com vs Toyota Motor Corporation

Related to Vertex Pharmaceuticals

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.